Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Evoke Group Acquires AboveNation Media

Huntsworth plc announced the acquisition of New York-based AboveNation Media LLC, adding to its collection of leading health, wellness and lifestyle marketing companies under Evoke Group.

Read More »

Novo’s diabetes pill impresses in first big study

The world’s largest diabetes drugmaker, Novo Nordisk, presented the first successful data from a large final-stage study of a pill the company hopes will transform the diabetes market.

Read More »

Study seeks to end antidepressant debate: the drugs do work

A vast research study that sought to settle a long-standing debate about whether or not anti-depressant drugs really work has found they are indeed effective in relieving acute depression in adults.

Read More »

U.S. health officials reverse stance on flu vaccine

An advisory committee of the U.S. CDC recommended the use of AstraZeneca’s FluMist Quadrivalent vaccine in the upcoming flu season, reversing its earlier position.

Read More »

ORIC Pharmaceuticals Snags $50 Million to Advance Lead Asset for Treatment-Resistant Cancers

A new chief executive officer and a fresh infusion of $50 million in Series C funding has given ORIC Pharmaceuticals Inc. a shot in the arm as the South San Francisco-based company continues to push development of its lead asset for treatment-resistant cancers.

Read More »

FDA Grants Evofem’s Amphora Fast Track Designation

The U.S. FDA granted San Diego-based Evofem Biosciences Fast Track designation for Amphora vaginal gel to prevent urogenital chlamydia infection in women.

Read More »

AbbVie’s Elagolix Hits Primary Endpoints for Uterine Fibroids

AbbVie and Neurocrine Biosciences’ Phase III ELARIS UF-1 clinical trial of elagolix for uterine fibroids hit its primary endpoint.

Read More »

11 Most Innovative Life Science Companies in the World

Fast Company recently published The World’s 50 Most Innovative Companies 2018, topping off its edition of the top 350 most innovative companies. Here is a look at the life science companies that made the list.

Read More »

Merck to Acquire Viralytics for $394 Million

Merck & Co. is driving forward in its quest to develop a premier immuno-oncology pipeline with the acquisition of Australia-based Viralytics Ltd. and its oncolytic immunotherapy treatments.

Read More »

Inception Digital Introduces Pando, the Newest Innovation in Remote Meeting Connectivity

Inception Digital – the premiere broadcast production and delivery company – announced the introduction of Pando, a groundbreaking meeting platform that enables face-to-face collaboration delivered remotely.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom